Wells Fargo maintains Overweight on Accenture, cuts target to $194
Wells Fargo analyst Jason Kupferberg maintains an Overweight rating on Accenture (NYSE: ACN) but reduces the price target to $194 from $200. The adjustment reflects a revised outlook while retaining a positive stance on the stock.

*this image is generated using AI for illustrative purposes only.
Wells Fargo analyst Jason Kupferberg has maintained an Overweight rating on Accenture (NYSE: ACN) while lowering the price target to $194 from $200. The revised target suggests a tempered outlook for the stock despite the continued positive stance from the firm.
The decision to lower the price target comes as the firm reassesses Accenture's valuation and market position. While the specific drivers for the reduction were not detailed, the maintenance of the Overweight rating indicates confidence in the company's long-term performance.
Rating and Price Target Details
The following table outlines the updated rating and price target for Accenture:
| Metric | Value |
|---|---|
| Rating | Overweight |
| Previous Price Target | $200 |
| New Price Target | $194 |
Accenture continues to be viewed favorably by Wells Fargo, as evidenced by the Overweight rating. The lower price target may reflect broader market conditions or company-specific factors that could influence near-term stock performance.
What specific market conditions or company-specific factors likely prompted the price target reduction?
How might this revised outlook influence investor sentiment toward other IT consulting firms?
What are the key growth drivers that support the long-term Overweight rating despite near-term caution?































